Gauruv Bose

14PUBLICATIONS
34CO-AUTHORS
AutoimmunityNeurology and neuromuscular diseasesMedical mycologyMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 10, 2025
Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21-FOXO1 axis in pathogenic T helper 17 cells.

Johnna Francis Varghese, Mai Fujiwara, Amrendra K Ajay

|Oct 09, 2023
Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity.

Gauruv Bose, Brian C Healy, Shrishti Saxena

|Jun 01, 2023
Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.

Alicia Gonzalez-Martinez, Gauruv Bose, Hrishikesh Lokhande

|Aug 11, 2022
Younger age at multiple sclerosis onset is associated with worse outcomes at age 50.

Gauruv Bose, Brian C Healy, Christian Barro

|Feb 17, 2021
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.

Gauruv Bose, Justin Graveline, Vignan Yogendrakumar

Pageof 3